Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions
Author:
Funder
Merck KGaA
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/29/5/1130/25083225/mdy102.pdf
Reference76 articles.
1. Induction chemotherapy in patients with resectable head and neck squamous cell carcinoma: a meta-analysis;Ma;World J Surg Oncol,2013
2. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer;Wolf;N Engl J Med,1991
3. Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study;Paccagnella;Ann Oncol,2010
4. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer;Vermorken;N Engl J Med,2007
5. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer;Posner;N Engl J Med,2007
Cited by 99 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. NMR-Based Metabolomics of Blood Serum in Predicting Response to Induction Chemotherapy in Head and Neck Cancer—A Preliminary Approach;International Journal of Molecular Sciences;2024-07-10
2. Tumor‐associated genetic amplifications impact extracellular vesicle miRNA cargo and their recruitment of nerves in head and neck cancer;The FASEB Journal;2024-07-04
3. Neoadjuvant programmed cell death 1 blockade combined with chemotherapy for locally advanced head and neck squamous cell carcinoma;Holistic Integrative Oncology;2024-06-27
4. Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial;Nature Communications;2024-06-19
5. Radiogenomics is Elevating Treatment Response Prediction in Head and Neck Squamous Cell Carcinoma;Academic Radiology;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3